BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report) shot up 7.1% during trading on Friday . The company traded as high as $11.00 and last traded at $10.82. 43,477 shares traded hands during mid-day trading, a decline of 30% from the average session volume of 61,929 shares. The stock had previously closed at $10.10.
BioStem Technologies Stock Up 7.1 %
The stock’s 50-day simple moving average is $13.98 and its 200 day simple moving average is $13.85. The company has a market cap of $180.39 million, a price-to-earnings ratio of 15.91 and a beta of -0.39.
About BioStem Technologies
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
See Also
- Five stocks we like better than BioStem Technologies
- Retail Stocks Investing, Explained
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How Investors Can Find the Best Cheap Dividend Stocks
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Investing in the High PE Growth Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
-sae-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}